GENMAB

EUIPO EUIPO 2000 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark GENMAB was filed as Word mark on 04/20/2000 at the European Union Intellectual Property Office.
It was registered as a trademark on 07/24/2001. The current status of the mark is "Trademark registered".

Trademark Details Last update: February 9, 2024

Trademark form Word mark
File reference 001622042
Application date April 20, 2000
Publication date December 26, 2000
Entry date July 24, 2001
Expiration date April 20, 2030

Trademark owner

Carl Jacobsens Vej 30
2500 Valby
DK

Trademark representatives

Axeltorv 2 1609 Copenhagen V DK

goods and services

1 Biochemicals, namely, monoclonal antibodies for in vitro or scientific research regarding cancer, acquired immune deficiency syndrome ("AIDS"), and other infectious diseases, autoimmune diseases, and cardiovascular diseases in class 1
5 Monoclonal antibody therapeutic pharmaceuticals for use in the treatment of cancer, acquired immune deficiency syndrome ("AIDS") and other infectious diseases, autoimmune diseases, and cardiovascular diseases in class 5

Trademark history

Date Document number Area Entry
August 17, 2023 Transfer / Change of address, Published
November 27, 2019 Extension, Trade mark renewed
August 16, 2017 Transfer / Change of address, Published
March 29, 2017 Change Representative, Published
October 11, 2016 Change Representative, Published
November 21, 2012 Transfer / Change of address, Published
February 10, 2011 Change Representative, Published
November 30, 2010 Transfer / Change of address, Published
March 22, 2010 Extension, Trade mark renewed
March 1, 2010 Change Representative, Published
August 20, 2007 Change Representative, Published
July 16, 2007 Transfer / Change of address, Published
March 25, 2006 Transfer / Change of address, Registered
November 15, 2001 Transfer / Change of address, Registered

ID: 11001622042